| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 06/06/2001 | EP1104460A1 Modulation of apoptosis with bid |
| 06/06/2001 | EP1104456A1 Engineered antigen-presenting cells expressing an array of antigens and uses thereof |
| 06/06/2001 | EP1104440A1 A g-protein coupled 7tm receptor (axor-1) |
| 06/06/2001 | EP1104309A2 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods |
| 06/06/2001 | CN1298451A Adenoviral vectors for treating disease |
| 06/06/2001 | CN1298445A Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth |
| 06/06/2001 | CN1298444A Insulin-like growth factor II antisense oligonucleotide sequences and methods of using same to modulate cell growth |
| 06/06/2001 | CN1298412A G-CSF receptor agonist antibodies and screening method therefor |
| 06/06/2001 | CN1298411A Caspase-8 interacting proteins |
| 06/06/2001 | CN1298298A Periadventitial delivery device |
| 06/06/2001 | CN1297905A Human ribosomal protein L14.22 as one new kind of polypeptide and polynuceotides encoding this polypeptide |
| 06/06/2001 | CA2290031A1 Methods and means for inducing apoptosis by interference in rna processing |
| 06/05/2001 | US6242667 Transgenic organisms having tetracycline-regulated transcriptional regulatory systems |
| 06/05/2001 | US6242666 Animal model for identifying a common stem/progenitor to liver cells and pancreatic cells |
| 06/05/2001 | US6242592 Process for the preparation of 2′-O-alkyl-guanosine, cytidine, and uridine phosphoramidites |
| 06/05/2001 | US6242590 Antisense modulation of zinc finger protein-217 expression |
| 06/05/2001 | US6242589 Phosphorothioate oligonucleotides having modified internucleoside linkages |
| 06/05/2001 | US6242579 Antigen found on a small subset of human hematopoietic cells which binds to monoclonal antibody MG1 |
| 06/05/2001 | US6242575 Antibodies for detecting p27 protein |
| 06/05/2001 | US6242572 Human G protein coupled lysophosphatidic acid receptor |
| 06/05/2001 | US6242568 Zinc finger protein derivatives and methods therefor |
| 06/05/2001 | US6242427 Methods of inhibiting phagocytosis |
| 06/05/2001 | US6242419 Genes encoding proteins expressed in lymph node stromal cells from flaky skin (fsn-/-) mice and their use in therapy. |
| 06/05/2001 | US6242259 Compositions and methods for packing of alphavirus vectors |
| 06/05/2001 | US6242254 Cell has dna encoding tetracycline responsive transcriptional activator linked to tissue-specific promoter and tetracycline operator minimal promoter linked to dna encoding sv40 t antigen; cell proliferation is controlled by tetracycline |
| 06/05/2001 | US6242249 Nucleotide sequences of trigger factor chaperones from staphylococcus; diagnosis; probes; primers; vaccines; bactericides; bacteriostats; antibodies; drug screening |
| 06/05/2001 | US6242220 Method for purifying covalently closed circular DNA |
| 06/05/2001 | US6242218 Dna construct for altering gene expression of endogenous granulocyte-colony stimulating factor in mammalian cell; gene therapy; culture production |
| 06/05/2001 | US6242212 Nucleotide sequences which code a protein for the diagnosis, detection and treatment of cancer |
| 06/05/2001 | US6241991 Aviadenovirus |
| 06/05/2001 | US6241982 Method for treating brain cancer with a conditionally lethal gene |
| 06/05/2001 | US6241710 Hypodermic needle with weeping tip and method of use |
| 06/05/2001 | CA1341246C Somatic cell gene therapy |
| 06/04/2001 | WO2001042474A2 Interferon-like molecules and uses thereof |
| 06/04/2001 | CA2395408A1 Interferon-like molecules and uses thereof |
| 05/31/2001 | WO2001038584A2 Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof |
| 05/31/2001 | WO2001038566A2 Screening method for candidate drugs |
| 05/31/2001 | WO2001038552A2 Excipient system that contains coating substances with enzymatically removable side-groups |
| 05/31/2001 | WO2001038548A2 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors |
| 05/31/2001 | WO2001038547A2 Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells |
| 05/31/2001 | WO2001038542A1 Ilk-2, an integtrin-linked kinase |
| 05/31/2001 | WO2001038540A1 A novel polypeptide, a human methionyl trna synthetase 29 and the polynucleotide encoding the polypeptide |
| 05/31/2001 | WO2001038535A1 Chimeric gene enabling expression of the gene or cdna of type i insulin-like growth factor (igf-i) in the pancreas and utilization thereof in genic therapy of diabetes mellitus |
| 05/31/2001 | WO2001038528A1 Cell proliferation inhibitory protein, polynucleotide, antisense polynucleotide to the polynucleotide, and cell proliferation inhibitors, cancer diagnostics, cancer remedies and compositions for gene therapy by using the same |
| 05/31/2001 | WO2001038523A1 A novel polypeptide, a human deafness-related gene 14 and the polynucleotide encoding the polypeptide |
| 05/31/2001 | WO2001038488A2 Gene expression by positive feedback activation of a cell type-specific promoter |
| 05/31/2001 | WO2001038486A2 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | WO2001038389A1 A new polypeptide-ribosomal protein l14.22 and the polynucleotide encoding it |
| 05/31/2001 | WO2001038386A1 A novel polypeptide - human sr splicing factor 52 and a polynucleotide encoding the same |
| 05/31/2001 | WO2001038379A1 A new polypeptide-human ribosomal protein l23 and the polynucleotide encoding it |
| 05/31/2001 | WO2001038361A1 Modified adenovirus fibre and uses |
| 05/31/2001 | WO2001038350A2 85kDa NEISSERIAL ANTIGEN |
| 05/31/2001 | WO2001038346A2 Short peptides to target epithelial cells |
| 05/31/2001 | WO2001038335A1 Phosphorus-containing dendrimers as transfection agents |
| 05/31/2001 | WO2001038322A1 Inhibitors of histone deacetylase |
| 05/31/2001 | WO2001037881A2 Gene therapy of hiv-positive patients by the expression of membrane-anchored gp41 peptides |
| 05/31/2001 | WO2001037864A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 05/31/2001 | WO2001037859A2 Pharmaceutical compositions containing compounds which increase or decrease tmtnf levels |
| 05/31/2001 | WO2001037857A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | WO2001037853A2 Methods and agents for the inhibition of smooth muscle cell proliferation |
| 05/31/2001 | WO2001037807A1 Modular targeted liposomal delivery system |
| 05/31/2001 | WO2001037671A1 Anti-angiogenic cellular agent for cancer therapy |
| 05/31/2001 | WO2001037665A1 Compositions and methods for drug delivery using amphiphile binding molecules |
| 05/31/2001 | WO2000077188A3 Dna pcv vaccine |
| 05/31/2001 | WO2000077032A3 Spermine:peptide-based surfactant compounds |
| 05/31/2001 | WO2000072880A3 Prevention and treatment of amyloidogenic disease |
| 05/31/2001 | WO2000066708A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 05/31/2001 | WO2000061754A3 Human proteins and polynucleotides encoding them |
| 05/31/2001 | WO2000055345A3 Therapy of cancer by insect cells containing recombinant baculovirus encoding genes |
| 05/31/2001 | WO2000045853A3 Treatment of tumors with genetically engineered herpes virus |
| 05/31/2001 | WO2000042165A3 Bone marrow-specific protein |
| 05/31/2001 | WO1999060124A3 Differentiation-associated sequences and methods of use therefor |
| 05/31/2001 | WO1999035255A9 Compositions and methods for regulated secretion from neuroendocrine cell lines |
| 05/31/2001 | WO1999028341A9 Maintenance of smooth muscle integrity by morphogenic proteins |
| 05/31/2001 | US20010002392 Administrated an effective amount of cartilage oligomeric matrix protein(COMP) to prevent or treat the rheumatoid arthritic condition of a mamal |
| 05/31/2001 | DE19956502A1 New composition comprising a carrier and a complex made from nucleic acid molecules and a charged copolymer useful in e.g. wound healing and for coating onto catheters is new |
| 05/31/2001 | DE19954444A1 Verfahren zum Schutz von Säugetierzellen mittels überexprimierter G-2/M-Zellzykluskoppler A method of protecting mammalian cells by means of overexpressed G-2 / M-Zellzykluskoppler |
| 05/31/2001 | CA2394914A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 05/31/2001 | CA2392697A1 Phosphorus-containing dendrimers as transfection agents |
| 05/31/2001 | CA2392490A1 Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells |
| 05/31/2001 | CA2392468A1 Gene therapy of hiv-positive patients by the expression of membrane-anchored gp41 peptides |
| 05/31/2001 | CA2392366A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | CA2392272A1 Modified adenovirus fibre and uses |
| 05/31/2001 | CA2391922A1 Excipient system that contains coating substances with enzymatically removable side-groups |
| 05/31/2001 | CA2391606A1 Modular targeted liposomal delivery system |
| 05/31/2001 | CA2391434A1 Anti-angiogenic cellular agent for cancer therapy |
| 05/31/2001 | CA2390465A1 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | CA2390344A1 85kda neisserial antigen |
| 05/31/2001 | CA2389667A1 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors |
| 05/30/2001 | EP1103615A1 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors |
| 05/30/2001 | EP1103614A1 Novel plasmid vector |
| 05/30/2001 | EP1103607A1 Enhancement of tmTNF levels for the sensitisation of tumours to sTNF and/or cytostatic drugs |
| 05/30/2001 | EP1103562A1 Novel g-protein coupled receptor protein and dna thereof |
| 05/30/2001 | EP1102862A1 Antisense oligonucleotides targeted to il-15 |
| 05/30/2001 | EP1102858A2 Cell lines for the propagation of mutated herpes viruses |
| 05/30/2001 | EP1102853A1 N-acetylglycosaminyltransferase genes |
| 05/30/2001 | EP1102851A1 Recombinant poliovirus for the treatment of cancer |
| 05/30/2001 | EP1102842A2 Antisense oligonucleotides for the inhibition of vegf expression |
| 05/30/2001 | EP1102785A1 COMPOSITIONS AND METHODS FOR DRUG DELIVERY USING pH SENSITIVE MOLECULES |
| 05/30/2001 | EP1102784A1 A compound containing a labile disulfide bond |